Apricus Biosciences Shares Up 32% Premarket After Co. Announces Signing Of Definitive Agreement To Merge With Privately-Held Seelos Therapeutic, Inc. In All-Stock Deal; Seelos Shareholders Will Receive APRI Common Shares And Own Approximately 86% Of Merge